库尔库在心血管疾病中的治疗潜力:向动脉样硬化病理生理学
Rajesh Yadav1, Shruti Mishra2, Rupesh Chaturvedi3
1Department of Dialysis Technology, Sharda School of Allied Health Sciences, Sharda University, Gautam Budh Nagar, Greater Noida, Uttar Pradesh 201310, India.
概括
黄素是一种天然化合物,通过减少炎症和改善血管健康,显示出对抗动脉样硬化的前景. 需要进一步的研究来优化其用于预防心血管疾病的交付.
科学领域:
- 心血管科学 心血管科学
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 动脉样硬化是导致心血管疾病的全球主要原因.
- 传统的治疗方法有局限性,这推动了对自然替代品的研究.
- 黄素,来自Curcuma longa,表现出抗炎和抗氧化特性.
研究的目的:
- 探索黄素作为抗动脉样硬化剂的潜力.
- 研究黄素对动脉样硬化的影响机制.
- 审查黄素疗效的临床前和临床证据.
主要方法:
- 对黄素对动脉样硬化标志物影响的临床前研究的综述.
- 对关于黄素对血管健康的影响的临床试验数据的分析.
- 探索黄素的分子点,包括NF-κB和MAPK通路.
主要成果:
- 在临床前模型中,黄素显示出抗炎,抗氧化和内皮保护作用.
- 观察到大动脉损伤面积减少和内皮功能改善.
- 临床试验表明,在风险人群中,对血管健康有潜在的益处.
结论:
- 由于其多方面的作用,黄素对动脉样硬化有显著的治疗潜力.
- 低生物可用性仍然是一个挑战,需要进一步研究先进配方.
- 强大的临床试验对于确定黄素的疗效和心血管疾病管理的最佳剂量至关重要.
相关概念视频
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Coronary Artery Disease I: Introduction
57
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
57
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
Coronary Artery Disease IV: Preventive Measures
34
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
34
Coronary Artery Disease II: Pathophysiology
36
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
36


